Gentle noise stimulation synchronized with an individual’s brainwaves boosted cardiovascular health, according to a recent study.
A recent Northwestern Medicine study found that patients with glioblastoma responded better or worse to immunotherapy depending on the presence of certain mutations in their tumors.
Northwestern Medicine scientists have discovered that an existing therapy used to treat Alzheimer’s disease might also work on patients with Primary Progressive Aphasia, a type of dementia that destroys language and currently has no treatment.
According to a recent study, a novel nanoparticle-based drug repaired neurons and improved microvasculature in a mouse model of spinocerebellar ataxia 1, a degenerative disease that affects the cerebellum.
Abnormal activation of a small population of neurons may contribute to motor learning and motor function deficits in patients with Parkinson’s disease, according to a recent study.
Northwestern Medicine investigators discovered a method to modulate levels of a protein that is known to drive inflammation, by manipulating levels of an amino acid known as serine.
A team of scientists has discovered the physiological function of APP, a protein long known to be associated with Alzheimer’s disease but whose normal function had remained elusive.
A one-time stem cell transplantation therapy for multiple sclerosis showed improvements over the current treatment, according to a preliminary trial.
Northwestern was recently awarded a five-year, $13.5 million grant from the National Institutes of Health to create a platform of app-based tools, called the MobileToolbox, to remotely assess cognitive function.